"As a leading academic health system, driving innovation is essential to our commitment to providing world-class care," said John Couris, president and CEO of Tampa General Hospital. "This recognition demonstrates our team's focus on adopting forward-thinking advancements in technology to maximize new approaches. The end result is better treatments and outcomes for patients now and long into future."
Nearly three years later, Nurse Sarah Lindsay volunteered to be the first American to receive this season’s shot: Pfizer-BioNTech 2023-24 COVID-19 vaccine. This mRNA formulation offers protection against BA.2, BA.2.86 “Pirola,” EG.5 “Eris,” XBB.1.5 COVID variants – needed immunity as COVID hospitalizations begin to rise ahead of the fall and winter season.
"As a leading academic health system, driving innovation is essential to our commitment to providing world-class care," said John Couris, president and CEO of Tampa General Hospital. "This recognition demonstrates our team's focus on adopting forward-thinking advancements in technology to maximize new approaches. The end result is better treatments and outcomes for patients now and long into future."